News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
Moderna Inc. and Cenra Healthcare enter joint agreement to co-promote mRNA respiratory vaccine portfolio in Taiwan, enhancing public health initiatives. Details undisclosed -
-
-
COMMUNIQUÉ DE PRESSE
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
Moderna initiates Phase 3 trial for mRNA-1403, an investigational norovirus vaccine, aiming to prevent infection from norovirus. Global recruitment has started
